BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18985481)

  • 1. Effect of fragile histidine triad gene on biologic properties of muco-epidermoid carcinoma cells.
    Liu F; Wu JZ; Li F; Li Y; Li J
    Cytotherapy; 2008; 10(7):753-8. PubMed ID: 18985481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
    Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA
    Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ectogenous fragile histidine triad gene inhibits the malignant phenotype of human lung cancer cell line A549 in vitro and in vivo].
    Zhang LQ; Wang H; Lai BT; Yue WT; Zhan XP; Yang XH; Zhang CY; Zhang TM
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 May; 28(5):333-6. PubMed ID: 15949315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The inhibition of fragile histidine triad gene on the proliferation and tumorigenicity of mucoepidermoid carcinoma cells].
    Liu F; Wu JZ; Li F; Li Y; Li J
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2008 Jun; 26(3):252-5. PubMed ID: 18705504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of ectogenous FHIT gene on reversing malignant phenotype of human lung adenocarcinoma cells A549].
    Wang Y; Zhuo Q; Qin Y; Yuan S; Sun Z; Wang Y; Chen X; Sun Z; Song Y; Yang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):225-9. PubMed ID: 12048684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of fragile histidine triad (FHIT) expression inhibits cell growth and induces apoptosis in cutaneous T-cell lymphoma cell line.
    Song X; Tian Z; Wang S; Peng Z; Feng J
    Cancer Invest; 2010 Dec; 28(10):1019-23. PubMed ID: 20690795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the FHIT gene favors bladder cancer development.
    Vecchione A; Sevignani C; Giarnieri E; Zanesi N; Ishii H; Cesari R; Fong LY; Gomella LG; Croce CM; Baffa R
    Clin Cancer Res; 2004 Nov; 10(22):7607-12. PubMed ID: 15569992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
    Werner NS; Siprashvili Z; Fong LY; Marquitan G; Schröder JK; Bardenheuer W; Seeber S; Huebner K; Schütte J; Opalka B
    Cancer Res; 2000 Jun; 60(11):2780-5. PubMed ID: 10850413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites.
    Ishii H; Mimori K; Inageta T; Murakumo Y; Vecchione A; Mori M; Furukawa Y
    Mol Cancer Res; 2005 Mar; 3(3):130-8. PubMed ID: 15798093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fhit regulates invasion of lung tumor cells.
    Joannes A; Bonnomet A; Bindels S; Polette M; Gilles C; Burlet H; Cutrona J; Zahm JM; Birembaut P; Nawrocki-Raby B
    Oncogene; 2010 Feb; 29(8):1203-13. PubMed ID: 19935706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells.
    Ishii H; Dumon KR; Vecchione A; Trapasso F; Mimori K; Alder H; Mori M; Sozzi G; Baffa R; Huebner K; Croce CM
    Cancer Res; 2001 Feb; 61(4):1578-84. PubMed ID: 11245468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma].
    Liu FX; Huang XP; Zhao CX; Xu X; Han YL; Cai Y; Wu RL; Wu M; Zhan QM; Wang MR
    Ai Zheng; 2004 Sep; 23(9):992-8. PubMed ID: 15363189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the expression profile of apoptotic esophageal cancer cells by adenoviral-fragile histidine triad treatment.
    Mimori K; Ishii H; Inoue H; Barnard GF; Mori M
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S205-9. PubMed ID: 19120899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell line.
    Cavazzoni A; Petronini PG; Galetti M; Roz L; Andriani F; Carbognani P; Rusca M; Fumarola C; Alfieri R; Sozzi G
    Oncogene; 2004 Nov; 23(52):8439-46. PubMed ID: 15361849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced acetylated histone H4 is associated with promoter methylation of the fragile histidine triad gene in resected esophageal squamous cell carcinoma.
    Tzao C; Sun GH; Tung HJ; Hsu HS; Hsu WH; Wang YC; Cheng YL; Lee SC
    Ann Thorac Surg; 2006 Aug; 82(2):396-401; discussion 401. PubMed ID: 16863736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fragile histidine triad expression in rhabdomyosarcoma].
    Wang SL; Yang GH; Bu H; Guo LX; Zhou Q; Zhang HY; Ye L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):176-8. PubMed ID: 15071908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between methylation of 5'-CpG islands and inactivation of FHIT gene in cervical cancer].
    Shi HR; Wu QH; Suo ZH; Nesland JM
    Ai Zheng; 2005 Jan; 24(1):7-11. PubMed ID: 15642192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of fragile histidine triad expression in prostate carcinoma.
    Fouts RL; Sandusky GE; Zhang S; Eckert GJ; Koch MO; Ulbright TM; Eble JN; Cheng L
    Cancer; 2003 Mar; 97(6):1447-52. PubMed ID: 12627509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
    Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M
    Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
    Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M
    Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.